www.bioscience.co.uk
Sales & Support: +44 (0)1223 316 855

*

Flumatinib (mesylate)

Catalogue number:
HY-13905-5mg
Supplier:
Size:
5 mg _$$_
Product is available in:
  • UK
  • Ireland
  • Europe
  • USA
  • Rest of World
£211.00 Shipping is calculated in checkout
This product is for research use only and is not for human consumption or therapeutic use.
CAS Number:

895519-91-2

Purity:

99.87

Molecular Weight:

658.69

Alternative Names:

HHGV678 mesylate

Product Description:

Flumatinib (HHGV678) mesylate is an orally active and selective inhibitor of Bcr-Abl. Flumatinib mesylate inhibits c-Abl, PDGFRβ and c-Kit with IC50 values of 1.2, 307.6 and 665.5 nM, respectively. Flumatinib mesylate inhibits Bcr-Abl autophosphorylation and Stat5 and Erk1/2 phosphorylation. Flumatinib mesylate inhibits tumor growth in chronic myelogenous leukemia model[1][2].

Storage Temperature:

4°C (Powder, sealed storage, away from moisture)

Details Cat number & supplier Size Price
Flumatinib (mesylate) HY-13905-50mg · MedChem Express
HY-13905-50mg
MedChem Express
50 mg £1081.00
50 mg
view
23-epi-26-Deoxyactein HY-139058-10mg · MedChem Express
HY-139058-10mg
MedChem Express
10 mg £1554.00
10 mg
view
Flumatinib (mesylate) HY-13905-25mg · MedChem Express
HY-13905-25mg
MedChem Express
25 mg £684.00
25 mg
view
23-epi-26-Deoxyactein HY-139058-5mg · MedChem Express
HY-139058-5mg
MedChem Express
5 mg £969.00
5 mg
view
Flumatinib (mesylate) HY-13905-10mg · MedChem Express
HY-13905-10mg
MedChem Express
10 mg £336.00
10 mg
view
SCD1 inhibitor-3 HY-139077-100mg · MedChem Express
HY-139077-100mg
MedChem Express
100 mg £2237.00
100 mg
view
Flumatinib (mesylate) HY-13905-100mg · MedChem Express
HY-13905-100mg
MedChem Express
100 mg £1715.00
100 mg
view
SCD1 inhibitor-3 HY-139077-10mg · MedChem Express
HY-139077-10mg
MedChem Express
10 mg £473.00
10 mg
view
SW157765 HY-139047-5mg · MedChem Express
HY-139047-5mg
MedChem Express
5 mg £113.00
5 mg
view
SCD1 inhibitor-3 HY-139077-1mL · MedChem Express
HY-139077-1mL
MedChem Express
1 ml £343.00
1 ml
view